Skip to main content
. Author manuscript; available in PMC: 2013 Jan 15.
Published in final edited form as: Dev Biol. 2012 Nov 1;373(2):373–382. doi: 10.1016/j.ydbio.2012.10.024

Figure 4. Biochemical and transcriptional response of skin to KrasG12D.

Figure 4

(A) Immunoblot analysis of phosphorylated downstream effector proteins (green) in wildtype and KrasG12D P4 skin. Samples show no significant change after normalized with total ERK (red), which also serves as a loading control. (B) Densitometry analysis of phosphorylated p90RSK, AKT, and ERK normalized to total ERK show no significant change of whole skin at baseline